675 Safety and tolerability of magrolimab combination therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma (RM-HNSCC)A. Dimitrios Colevas, Douglas Adkins, Katie Kerrigan et al.|Regular and Young Investigator Award Abstracts|2023Cited by 1
Safety and Tolerability of Magrolimab Combination Therapy in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (RM-HNSCC)A. Dimitrios Colevas, Douglas Adkins, Diogo Alpuim Costa et al.|International Journal of Radiation Oncology*Biology*Physics|2024Cited by 1
A phase 2 study of magrolimab combination therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma: ELEVATE HNSCC.A. Dimitrios Colevas, Douglas Adkins, José Dinis et al.|Journal of Clinical Oncology|2023Cited by 0